Literature DB >> 27371642

The use of the International Classification of Functioning, Disability and Health to classify the factors influencing mobility reported by persons with an amputation: An international study.

Seema Radhakrishnan1, Friedbert Kohler1, Christoph Gutenbrunner2, Arun Jayaraman3, Jianin Li4, Karin Pieber5, Carolina Schiappacasse6.   

Abstract

BACKGROUND: Amputation of lower limb results in limitations in mobility which are amenable to multiple rehabilitation interventions. The challenges faced by the persons with lower limb amputation vary internationally. The International Classification of Functioning, Disability and Health provides a common language to describe the function of persons with lower limb amputation across various countries.
OBJECTIVES: This article reports the concepts in mobility important to persons with lower limb amputation across six countries using the International Classification of Functioning, Disability and Health. STUDY
DESIGN: Qualitative study using focus groups and individual interviews.
METHODS: Focus groups and individual interviews of persons with lower limb amputation were organised across six countries to identify the issues faced by patients with an amputation during and after their amputation, subsequent rehabilitation and on an ongoing basis in their daily life. Meaningful concepts were extracted from the responses and linked to suitable second-level and where applicable third-level International Classification of Functioning, Disability and Health categories. International Classification of Functioning, Disability and Health categorical frequencies were analysed to represent the prevalence and spread of International Classification of Functioning, Disability and Health categories by location.
RESULTS: A total of 133 patients were interviewed. A large percentage (93%) of the identified concepts could be matched to International Classification of Functioning, Disability and Health categories for quantitative analysis.
CONCLUSION: The important concepts in mobility were similar across different countries. The comprehensiveness of International Classification of Functioning, Disability and Health as a classification system for human function and its universality across the globe is demonstrated by the large proportion of the concepts contained in the interviews from across the study centres that could be matched to International Classification of Functioning, Disability and Health categories. Clinical relevance The activity and participation restrictions faced by a person with lower limb amputation vary internationally and are amenable to multiple rehabilitation interventions. The International Classification of Functioning, Disability and Health may provide a common language to report and quantify the various concepts important to the patient in their rehabilitation journey.

Entities:  

Keywords:  Developing countries; Disability and Health; International Classification of Functioning; mobility; outcome measurement; patient perspective; prosthetics; prosthetics and orthotics in developing countries; rehabilitation; rehabilitation of amputees

Mesh:

Year:  2016        PMID: 27371642     DOI: 10.1177/0309364616652016

Source DB:  PubMed          Journal:  Prosthet Orthot Int        ISSN: 0309-3646            Impact factor:   1.895


  2 in total

1.  Adults with unilateral lower-limb amputation: greater spatial extent of pain is associated with worse adjustment, greater activity restrictions, and less prosthesis satisfaction.

Authors:  Jaclyn Megan Sions; Emma Haldane Beisheim-Ryan; Ryan Todd Pohlig; Mayank Seth
Journal:  Scand J Pain       Date:  2022-02-01

2.  Development of a core outcome set for studies involving patients undergoing major lower limb amputation for peripheral arterial disease: study protocol for a systematic review and identification of a core outcome set using a Delphi survey.

Authors:  Graeme K Ambler; David C Bosanquet; Lucy Brookes-Howell; Emma Thomas-Jones; Cherry-Ann Waldron; Adrian G K Edwards; Christopher P Twine
Journal:  Trials       Date:  2017-12-28       Impact factor: 2.728

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.